IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $88,000 | +104.7% | 2,893 | +128.7% | 0.01% | +100.0% |
| Q3 2021 | $43,000 | -14.0% | 1,265 | +1.4% | 0.00% | -25.0% |
| Q2 2021 | $50,000 | -60.6% | 1,247 | -55.7% | 0.00% | -63.6% |
| Q1 2021 | $127,000 | -20.6% | 2,817 | -0.4% | 0.01% | -26.7% |
| Q4 2020 | $160,000 | +27.0% | 2,829 | +6.7% | 0.02% | +7.1% |
| Q3 2020 | $126,000 | +65.8% | 2,651 | +65.3% | 0.01% | +40.0% |
| Q1 2020 | $76,000 | -11.6% | 1,604 | +13.7% | 0.01% | +11.1% |
| Q4 2019 | $86,000 | +3.6% | 1,411 | +2.2% | 0.01% | 0.0% |
| Q3 2019 | $83,000 | -1.2% | 1,381 | +5.5% | 0.01% | 0.0% |
| Q2 2019 | $84,000 | +300.0% | 1,309 | +395.8% | 0.01% | +80.0% |
| Q1 2019 | $21,000 | +2000.0% | 264 | +1785.7% | 0.01% | – |
| Q3 2018 | $1,000 | 0.0% | 14 | +27.3% | 0.00% | – |
| Q3 2017 | $1,000 | -98.9% | 11 | -99.3% | 0.00% | -100.0% |
| Q4 2015 | $93,000 | – | 1,516 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |